K

Keros Therapeutics
D

KROS

55.850
USD
2.10
(3.91%)
مغلق
حجم التداول
7,539
الربح لكل سهم
-5
العائد الربحي
-
P/E
-11
حجم السوق
2,262,338,793
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    AMGN
    AMGN
    -12.22
    (-4.13%)
    294.4 USD
    B
    BEAM
    -2.275
    (-8.65%)
    24.035 USD
    C
    CRSP
    0.360
    (0.77%)
    47.280 USD
    E
    EDIT
    -0.11500
    (-4.14%)
    2.66500 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    MRNA
    MRNA
    -2.950
    (-7.42%)
    36.830 USD
    N
    NTLA
    -1.165
    (-7.71%)
    13.955 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    25.63 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    VRTX
    VRTX
    -18.53
    (-3.83%)
    450.72 USD
    المزيد
الأخبار

العنوان: Keros Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.